GetBusy (LON:GETB – Get Free Report) issued its quarterly earnings results on Monday. The company reported GBX (0.84) earnings per share (EPS) for the quarter, Digital Look Earnings reports. GetBusy had a negative net margin of 5.45% and a positive return on equity of 34.82%.
GetBusy Stock Performance
GetBusy stock traded up GBX 1 during mid-day trading on Friday, reaching GBX 78. 62,939 shares of the company were exchanged, compared to its average volume of 51,329. The firm’s 50-day simple moving average is GBX 70.82 and its two-hundred day simple moving average is GBX 70.26. GetBusy has a twelve month low of GBX 55.10 and a twelve month high of GBX 95. The firm has a market cap of £39.54 million, a PE ratio of -27.37 and a beta of 0.39. The company has a debt-to-equity ratio of -85.48, a quick ratio of 0.44 and a current ratio of 0.36.
Insider Activity
In related news, insider Paul Haworth bought 13,188 shares of the company’s stock in a transaction dated Monday, September 7th. The shares were acquired at an average price of GBX 76 per share, with a total value of £10,022.88. Insiders own 38.26% of the company’s stock.
About GetBusy
GetBusy plc, through its subsidiaries, develops and sells document and task management software products in the United Kingdom, the United States, Australia, and New Zealand. The company offers Workiro and Virtual Cabinet for document workflow management, client portals, and digital signatures; SmartVault for enterprise content management; and HELLOPLAN for meeting scheduling and management. It also provides a range of tools and end-to-end workflows, such as digital asset and document management, tailored templates, quotes/proposal development, form-fill, authentication, e-signatures and approvals, workflow and task management, chat, and complex digital certification.
Featured Articles
- Five stocks we like better than GetBusy
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for GetBusy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GetBusy and related companies with MarketBeat.com's FREE daily email newsletter.
